Changing Therapeutic Approaches in Neovascular AMD and DME

home / insights / changing-therapeutic-approaches-in-neovascular-amd-and-dme

Judy Kim, MD and Peter Kaiser, MD present a comprehensive discussion on evolving therapeutic strategies for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), addressing barriers like step therapy, discuss the potential use of biosimilars, along with the efficacy and safety of newer therapies such as faricimab and high-dose aflibercept.

© 2024 MJH Life Sciences

All rights reserved.